STAT1 and breast neoplasm: Therefore, modulating STAT1 - a master regulator of collective immunoregulatory factors, using STAT1 inhibitor in MCT-primed breast tumor effectively shifted the immune homeostasis in the favor of immunogenicity, which resulted in a much improved response to ICB (Fig. 6f, j).